Patients with eosinophilic esophagitis (EoE) often describe the condition as painful, disruptive and frightening.

The prevalence of eosinophilic esophagitis is higher among patients with atopic diseases than among those without, a new ...

At 12 months, 2/3rds of Cohort 5 patients (48mg dose, 4mg per site) remained in clinical remission after their treatment with ...

Celldex Therapeutics (CLDX) experienced a share price increase of 19% over the last quarter, following significant developments in its clinical programs. Recently, the company announced promising ...

This root vegetable has been used for thousands of years for its medicinal properties, but it's important to know how much ...

Indeed, the FDA did respond to Phathom’s Citizen Petition and agreed that VOQUEZNA (that is, its active moiety, vonoprazan) ...

A sprinkling of horseradish may be an acquired taste, but the pungent spice comes with some major health benefits you don’t ...

However, a newly published meta-analysis in gastroenterology raises a crucial clinical dilemma: Could the treatment itself, intended to heal, paradoxically increase the risk of reflux oesophagitis (RE ...

Research Capital analyst Andre Uddin has maintained a “Speculative Buy” rating and C$12.00 target price on Eupraxia ...

Apogee Therapeutics, Inc., (Nasdaq: APGE), a clinical-stage biotechnology company advancing optimized, novel biologics with potential for ...